This is an aggregated industry headline. Read the full story at Drug Channels →
Protecting Gross-to-Net Performance Through Single-Channel Ecosystems
Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that growing pressure on drug pricing is exposing structural inefficiencies in gross-to-net (GTN) across traditional distribution channels. He argues that single-channel ecosystems can better coordi
By Drug Channels
· May 15, 2026
· via Drug Channels
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
With a pediatric approval in hand for Afrezza, MannKind may finally have the boost it needs to make an impact …
The WeekFierceBiotech ↗
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T …
The WeekBriefing
Allogene’s founding CEO steps down, Agios halts development of tebapivat, AbbVie gains approval for Decnupaz, …